Format

Send to

Choose Destination
Breast Cancer Res. 2008;10(6):217. doi: 10.1186/bcr2207. Epub 2008 Dec 22.

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.

Author information

1
Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Abstract

Eph receptor tyrosine kinase signaling regulates cancer initiation and metastatic progression through multiple mechanisms. Studies of tumor-cell-autonomous effects of Eph receptors demonstrate their dual roles in tumor suppression and tumor promotion. In addition, Eph molecules function in the tumor microenvironment, such as in vascular endothelial cells, influencing the ability of these molecules to promote carcinoma progression and metastasis. The complex nature of Eph receptor signaling and crosstalk with other receptor tyrosine kinases presents a unique challenge and an opportunity to develop therapeutic intervention strategies for targeting breast cancer.

PMID:
19144211
PMCID:
PMC2656900
DOI:
10.1186/bcr2207
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center